Brief: Pieris Pharmaceuticals Inc - Net Loss Was $5.1 Million Or $0.07 Per Share For The Quarter Ended March 31, 2022
May 11 (Reuters) - Pieris Pharmaceuticals Inc PIRS.O :
* PIERIS PHARMACEUTICALS INC - NET LOSS WAS $5.1 MILLION OR
$0.07
PER SHARE FOR THE QUARTER ENDED MARCH 31, 2022
* PIERIS PHARMACEUTICALS INC - BELIEVES REPORTED CASH IS
SUFFICIENT TO FUND OPERATIONS INTO THE FOURTH QUARTER OF 2023
Further company coverage: PIRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palvella Therapeutics
See all newsPalvella Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Palvella Therapeutics Q2 net loss widens on higher expenses
Brief: Palvella Therapeutics Announces New Data From The Phase 2 Toiva Trial Of Qtorin™ Rapamycin In Cutaneous Venous Malformations
Brief: Palvella Therapeutics Announces Uplisting To The Nasdaq Global Market
Palvella Therapeutics' Q1 net loss widens on higher costs